The potential impact on tuberculosis of interventions to reduce undernutrition in the WHO South-East Asian Region: a
Sandip Mandal1, Vineet Bhatia2, Anurag Bhargava3
1John Snow India, New Delhi, India.
Background:
Undernutrition is a major risk factor for TB incidence in the WHO South-East (SE) Asia Region. We examined the potential impact of addressing undernutrition as a preventive measure, for reducing TB burden in region.
Methods:
We developed a deterministic, compartmental mathematical model, capturing undernutrition and its associated excess risk of TB, amongst countries in the Region. We simulated two types of interventions: (i) nutritional rehabilitation amongst all close contacts of TB patients, and (ii) an illustrative, population-wide scenario where 30% of people with undernutrition would be nutritionally rehabilitated each year. We also simulated this impact with additional measures to improve the TB care cascade.
Findings:
The impact of nutritional interventions varies by country. For example, in India nutritional rehabilitation of 30% of undernourished population each year would avert 15.9% (95% Uncertainty Intervals (UI) 11.8-21.3) of cumulative incidence between 2023 and 2030, contrasting with 4.8% (95% UI 2.9-9.5) for Bhutan, which has only 10.9% prevalence of undernutrition. Reductions in cumulative mortality range from 11.6% (95% UI 8.2-17.1) for Bhutan, to 26.0% (95% UI 22.4-30.8) for India. Comparable incremental reductions in TB burden arise when combined with measures to improve the TB care cascade. Overall, nutritional interventions in the general population would increase incidence reductions by 2-3 fold, and mortality reductions by 5-6 fold, relative to targeting only contacts.
Interpretation:
Nutritional interventions could cause substantial reductions in TB burden in the Region. Their health benefits extend well beyond TB, underlining their importance for public health.
Funding:
None.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
